Novavax (NVAX) 10-K2012 FY Annual report

Filed: 12 Mar 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: adult, advice, Advisory, advocated, Africa, aftermath, al, arrived, articulated, attaining, Ayer, baseline, billion, bite, bound, burden, Camber, canine, central, Centre, childbearing, China, circulating, competitor, contemplated, convenience, couldexceed, criterion, Datamonitor, deny, devastation, die, diligently, discretion, divided, driven, Education, Electric, endemic, ethically, expended, expenditure, fifty, fighting, Flublok, France, Germany, grossly, heading, highest, imposed, inaccurate, inappropriate, increasingly, interval, intheir, intramuscular, invariably, IPR, isa, Italy, Lancet, led, left, light, link, logistically, Machinery, malaria, match, maternal, mentioned, micelle, Nair, newborn, Notably, Obama, opposed, ordisposition, outdoor, overhaul, page, panel, parallel, payer, people, percent, pharmacy, phosphate, postmarketing, PPACA, pregnancy, pregnant, prophylactic, RA, reactogenicity, redemption, regulationsallow, reproductive, retrofit, rural, SA, satisfactory, sensitive, seroprotection, shelf, shortly, slight, standing, statistically, steering, substantive, suggest, swelling, thatallow, thefollowing, thePublic, timeframe, top, trimester, turn, UK, unbilled, uncertainty, unclear, undelivered, underreported, underway, unnecessary, untreated, valuable, Virology, visually, waiting, widespread, withheld, youngest

Removed: accrue, add, aggressively, agreed, allocation, amend, assistance, assumed, authoritative, belief, bidding, bond, calendar, Cervarix, combat, commenced, committed, Commonwealth, comparing, complexity, constructed, convertible, cotton, culmination, de, Designation, disaggregation, discount, discounted, distributed, dozen, Dutch, enable, Engerix, Equiserve, expedited, ferret, flu, gather, HB, identifiable, induced, inhibition, inoculated, Institutional, insurer, intent, Investor, Junior, Kelly, Laboratorio, lethal, liquidating, MD, media, Mexico, mice, Mitchell, modified, Occupation, owed, Participating, pill, pledged, point, poison, preferred, presently, prospectively, protective, Rahul, rating, ratio, receiving, Recombivax, redeemable, reflected, repay, residual, saleable, separating, shareholder, Singhvi, SOHL, Subtopic, surviving, takeover, tender, tested, thwart, Trizzino, twelve, underlying, unique, vote

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NVAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We have issued our reports dated March 12, 2013, with respect to the financial statements, schedule, and internal control over financial reporting included in the Annual Report of Novavax, Inc. on Form 10-K for the year ended December 31, 2012. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Novavax, Inc. on Forms S-3 (No. 333-165496 effective April 27, 2010; No. 333-118210 effective August 13, 2004; No. 333-118181 effective August 12, 2004; and No. 333-22685 effective March 4, 1997) and on Forms S-8 (No. 333-183113 effective August 7, 2012; No. 333-145298 effective August 9, 2007; No. 333-130990 effective January 12, 2006; No. 333-110401 effective November 12, 2003; No. 333-97931 effective August 9, 2002; No. 333-46000 effective September 18, 2000; No. 333-77611 effective May 3, 1999; No. 33-80279 effective December 11, 1995; No. 33-80277 effective December 11, 1995).

/s/ Grant Thornton LLP

Mclean, Virginia

March 12, 2013